The simple, post-meal reminder of Bayer's CONTOUR^® blood glucose meter was shown to help insulin users achieve success in changing testing behaviors. ²

EASY TO LEARN AND USE

• Insert the test strip and test your blood glucose level — it's that simple

• Identify trouble spots with personalized HI/LO target range and summary of your blood glucose test results

• See effect of food choices on your blood glucose levels with pre-meal and post-meal markers³

• No Coding™ technology eliminates inaccurate blood glucose test results due to user miscoding

• 7-, 14- and 30-day averages of your blood glucose levels

• Fast, 5-second test time with tiny sample size — 0.6 μL

References:

1 Harrison B, Leazenby C, Halldorsdottir S. accuracy of the CONTOUR^®  blood glucose monitoring system. J Diabetes Sci Technol. 2011;5(4):1009-1013.
2. Bergenstal RM, Bode B, Tamler R, et al. ACT: Actions with the^® blood glucose meter and behaviors in frequent testers [abstract 2063-P0]. Diabetes. 2010;59 (suppl 1):A5 40. Study sponsored by Bayer.
3 IDF. Guideline for management of postmeal glucose. 2007.

Learning to use your CONTOUR^® meter? Check out the videos and user guides below for product demonstrations and step by step instructions for your CONTOUR^® meter.

Performing a Test >

Setup and Maintenance >

The Microlet 2 Lancing System >

Safe Lancet Disposal >

Additional Assistance >

Easy for patients to learn and test

CONTOUR^® strip technology ensures user accuracy.^1,2

No Coding™ technology

PRE- AND POST-MEAL MARKERS

CONTOUR^®'s pre- and post-meal markers and test reminder, with 7-, 14-, and 30-day averages, help your patients understand and monitor their postprandial plasma glucose (PPG). PPG is an important glycemic target and contributes significantly to overall glycemia in patients with an A1C level equal to or below 8.4%.^1-5

PROGRAMMABLE HI/LO SETTINGS

Personalized target ranges and test result summary help patients identify trouble spots such as hypoglycemia. The ADA guidelines recommend that for non-pregnant adults glycemic goals should be individualized based on:⁶

• Duration of diabetes

• Age/life expectancy

• Comorbid conditions

• Known CVD or advanced microvascular complications

• Hypoglycemia unawareness

• Individual patient considerations

With the CONTOUR® programmable HI/LO settings, your patients' meters can be personalized to account for their unique monitoring needs

PROVEN ACCURACY

With 99.3% accuracy, the CONTOUR® meter meets International Organization for Standardization accuracy requirements. (ISO15197:2003)  CONTOUR^® features were designed to reduce sources of error:

• No Coding™ technology

• No interference with maltose, galactose, oxygen, or many other common interfering substances^†

• Automatic hematocrit correction^‡

References:

• 1 AACE. Endocr Pract. 2007;13(suppl):3-68.

• 2 IDF. Guideline for management of postmeal glucose. 2007.

• 3 Monnier L et al. Diabetes Care. 2003;26:881-885.

• 4 Monnier L, Colette C. Curr Diab Rep. 2008;8:368-374.

• 5 Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the northern California kaiser permanente diabetes registry. Am J Med. 2001;111:1–9.

• 6 ADA. Diabetes Care. 2010;33:S11-S61.

• 7 Bayer's CONTOUR^® test strips with GDH-FAD chemistry cross-react with xylose. Do not use CONTOUR^® test strips during or shortly after a xylose absorption test.

• † Such as ascorbic acid and acetaminophen.

• ‡ From 0% to 70%.